$2.36T
Total marketcap
$77.84B
Total volume
BTC 50.59%     ETH 14.77%
Dominance

bioXXmed AG T5O.F Stock

0.47 EUR {{ price }} 32.402233% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
2.85M EUR
LOW - HIGH [24H]
0.47 - 0.47 EUR
VOLUME [24H]
15 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.13 EUR

bioXXmed AG Price Chart

bioXXmed AG T5O.F Financial and Trading Overview

bioXXmed AG stock price 0.47 EUR
Previous Close 1.85 EUR
Open 1.85 EUR
Bid 1.88 EUR x 18000
Ask 1.96 EUR x 18000
Day's Range 1.85 - 1.85 EUR
52 Week Range 1.09 - 3.5 EUR
Volume 2.74K EUR
Avg. Volume 0 EUR
Market Cap 9.76M EUR
Beta (5Y Monthly) 1.476245
PE Ratio (TTM) N/A
EPS (TTM) -0.13 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

T5O.F Valuation Measures

Enterprise Value 5.83M EUR
Trailing P/E N/A
Forward P/E -2.1264367
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 219.45746
Price/Book (mrq) 0.43662968
Enterprise Value/Revenue 131.022
Enterprise Value/EBITDA -4.144

Trading Information

bioXXmed AG Stock Price History

Beta (5Y Monthly) 1.476245
52-Week Change -45.58%
S&P500 52-Week Change 20.43%
52 Week High 3.5 EUR
52 Week Low 1.09 EUR
50-Day Moving Average 2.15 EUR
200-Day Moving Average 2.08 EUR

T5O.F Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 5 EUR
Shares Outstanding 5.14M
Float N/A
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.11%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) June 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 0%
Operating Margin (ttm) -3190.31%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -4.037%
Return on Equity (ttm) -18.27%

Income Statement

Revenue (ttm) 44.48K EUR
Revenue Per Share (ttm) 0.009 EUR
Quarterly Revenue Growth (yoy) -3.40%
Gross Profit (ttm) 44.63K EUR
EBITDA -1406322 EUR
Net Income Avi to Common (ttm) -3937847 EUR
Diluted EPS (ttm) -0.98
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 4.1M EUR
Total Cash Per Share (mrq) 0.8 EUR
Total Debt (mrq) 418.88K EUR
Total Debt/Equity (mrq) 1.92 EUR
Current Ratio (mrq) 29.853
Book Value Per Share (mrq) 4.237

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of bioXXmed AG

Country Germany
State N/A
City Darmstadt
Address N/A
ZIP 64295
Phone N/A
Website https://cytotools.de
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.

Q&A For bioXXmed AG Stock

What is a current T5O.F stock price?

bioXXmed AG T5O.F stock price today per share is 0.47 EUR.

How to purchase bioXXmed AG stock?

You can buy T5O.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for bioXXmed AG?

The stock symbol or ticker of bioXXmed AG is T5O.F.

Which industry does the bioXXmed AG company belong to?

The bioXXmed AG industry is Biotechnology.

How many shares does bioXXmed AG have in circulation?

The max supply of bioXXmed AG shares is 6.02M.

What is bioXXmed AG Price to Earnings Ratio (PE Ratio)?

bioXXmed AG PE Ratio is now.

What was bioXXmed AG earnings per share over the trailing 12 months (TTM)?

bioXXmed AG EPS is -0.13 EUR over the trailing 12 months.

Which sector does the bioXXmed AG company belong to?

The bioXXmed AG sector is Healthcare.